AMAmal Mahmoud Mohamed

Amal Mahmoud Mohamed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amal Mahmoud Mohamed has a total of 612 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deciphering copy number variations and gene implications in an Egyptian cohort with autism spectrum disorders

    by Amal M. Mohamed, Ola M. Eid, Khalda S. Amr, Rana Mahrous, Maha Hemimi, Amal Elsaeid, Peter S. F. Erian, Sally Gharib, Shymaa H. Hussein, Phoebe M. Abd El-Massieh, et al.

    Genetic factors are major contributors to autism spectrum disorders (ASD), with copy number variations (CNVs) playing a significant role. Our objective was


  • Open Access

    Comparative Analysis of Three Methods to Produce Diagnostic FISH Probes: Nick Translation, PCR Amplification and Chromosome Microdissection

    by Amal Mahmoud Mohamed, Maha Mohamed Eid, Ola Mohamed Eid, Shymaa H Hussein, Wael Mahmoud, Amir M.H. Salem, Feryal Sherif, Kamal M.A. Khalil, Mona Lotfi Essawi, Heba Amin Hassan

    Introduction: Fluorescence in situ hybridization (FISH) probes are vital diagnostic tools used to identify genetic disorders and malignancies. These probes enable precise localization of specific DNA sequences within chromosomes, making them crucial for both research and clinical diagnostics. Aim: The aim of this study is to evaluate and compare the effectiveness of three distinct methods for generating FISH probes by assessing the quality, advantages, and limitations of each. We aimed to provide insights into their suitability for producing locus-specific identifier and whole chromosome paint probes for diagnostic applications. Methods: In all used methods we followed the guidelines established by the American College of Medical Genetics (ACMG) for FISH probe production. We employed three methods to generate diagnostic probes: 1- Nick Translation to incorporate the labeled dyes into DNA segments from BAC clones or chromosome-specific DNA as templates. 2- PCR Amplification and Labeling using genomic DNA as a template and specific primers 3- Chromosome Microdissection using laser dissection microscope (LDM) to dissect and isolate specific chromosomes for further amplification. Results: Using BAC clones and nick translation, we developed locus-specific probes for chromosomes 6p, 6q, 1p36, and PAR1. Furthermore, by using chromosome-specific DNA templates and nick translation, we successfully produced WCPs for chromosomes 1, 4, 6, 14, 22, and X. PCR amplification and Labeling Using specific primers, we successfully produced alpha-satellite probes for several chromosome centromeres which were published before. Degenerate oligonucleotide-primed PCR (DOP-PCR) was employed to amplify a whole chromosome paint (WCP) for chromosome 13. Chromosome microdissection enabled the production of chromosome 6 centromere; however, amplifying small DNA quantities remains a challenge. Conclusion: Nick translation is the most effective and generative method for producing locus-specific probes and WCPs due to its reproducibility, accuracy, and stability. PCR-based methods are efficient for short unique repetitive sequences of chromosomes centromere. DOP-PCR is effective for amplification of entire chromosomes. While chromosome microdissection is promising, optimizing DNA amplification from very small DNA quantity is critical. The use of BAC clones ensures a sustainable resource for developing multiple locus-specific and whole chromosome paint probes, significantly addressing our research needs.

  • Open Access

    Molecular characterization of imprinting disorders: Beckwith–Wiedemann, Silver–Russell, and Prader-Willi syndromes in Egyptian patients

    by Amal M. Mohamed, Ola Eid, Marwa Farid, Engy Ashaat, Ghada M. H. Abdel-Salam, Hala T. El-Bassyouni, Mahmoud Essa, Rana Mahrous, Peter S. F. Erian, Khaled M. Refaat, et al.

    Background: Imprinted genes, characterized by monoallelic expressions (either maternal or paternal), they are crucial for normal growth and development. Disruption of their monoallelic expressions leads to imprinting disorders (ImpDis). The aim of this study is to achieve proper diagnosis of ImpDis in Egyptian patients through clinical evaluation and genetic testing, emphasizing certain clinical manifestations that may indicate ImpDis to provide accurate diagnosis and genetic counseling. Methods: Fifty-three patients, either clinically evaluated for Impaired Disposition (ImpDis) or suspected to have it, were referred from the outpatient genetic clinics at the National Research Center, Egypt. Nineteen patients displayed clinical manifestations of ImpDis syndromes, while 34 showed signs affecting growth, which suggested ImpDis. These growth-related symptoms included growth retardation, feeding problems, failure to thrive, hypoglycemia, obesity, hemihypertrophy, asymmetry, and overgrowth. Of the 19 patients with syndromic ImpDis, 8 were clinically diagnosed with Silver-Russell syndrome (SRS), 7 with Prader-Willi syndrome (PWS), and 4 with Beckwith-Wiedemann syndrome (BWS). We employed methylation-specific multiple ligation-dependent probe amplification (MS-MLPA) for all patients, SNP-array testing for 12 patients, and whole exome sequencing (WES) for one patient. Results: In patients with Silver-Russell syndrome (SRS), one patient exhibited hypermethylation of the GRB10 and MEST genes, along with segmental uniparental disomy (UPD) on chromosome 7 (patient 1). Another patient had a variant in the HMGA2 gene (NM_001300918.1:c.310dup), which, according to the American College of Medical Genetics (ACMG) criteria, was classified as PM2 VUS (patient 2). In patients with Prader-Willi syndrome (PWS), one patient showed hypermethylation of the SNPRN gene (patient 3). In patients with Beckwith-Wiedemann syndrome (BWS), two displayed hypomethylation of the KCNQ-CR region (patients 4 and 5). Among the group of patients with symptoms suggestive of ImpDis, no methylation defects were detected through MS-MLPA. Conclusion: It is crucial to diagnose ImpDis accurately, as understanding the exact cause of ImpDis is important for genetic counseling and personalized medicine. Early diagnosis enables timely interventions, which can improve developmental outcomes. Precision in diagnosis helps differentiate between conditions with overlapping clinical features. HMGA2 mutation should be verified in SRs patients with negative 11p15 methylation defect and matUPD7.


  • Open Access

    Generation of Dual-Color FISH probes targeting 9p21, Xp21, and 17p13.1 loci as diagnostic markers for some genetic disorders and cancer in Egypt

    by Amal M. Mohamed, Maha Eid, Ola Eid, Shymaa H Hussein, Wael Mahmoud, Rana Mahrous, Khaled Refaat, Marwa Farid


  • Interstitial 8p deletion in two patients with the expansion of phenotype and possibility of contribution of PINX1 gene and GATA4 rs3729856 variant in absent nails

    by Amal Mohamed, Wael M. Mahmoud, Alaaeldin Fayez, Asaad Elgerzawi, Engy Ashaat, Maha S Zaki, Nivine Helmy, Ola M. Eid, Alaa K Kamel

    The short arm of chromosome 8 is subjected to recurrent genomic imbalances. We aimed to delineate the genotype phenotype correlations to the different 8p deleted segments and predict the candidate gene for absent nails (anonychia). In this study we present two patients with interstitial 8p deletion. The first is a male patient presented with failure to thrive, seizures, hypotonia, absent nails, congenital heart, microcephaly, and hypogenesis of corpus callosum. Array CGH showed 18.6 Mb in 8p23.2p21.3 deletion that involved GATA4 gene. Sequencing for GATA4 gene disclosed likely pathogenic variant in the other allele. The second patient was a female presented with developmental delay, dysmorphic features, microcephaly, hypotonia, atrophic brain, and hypogenesis of corpus callosum. Array CGH showed a 25.6 Mb 8p22p12 deletion. We divided the deleted regions into three parts, and we tried to specify phenotype correlated to each region. We found rs3729856 (Ser378Gly) variant, which is a likely pathological in GATA4 gene, we predict that anonychia in the 1st patient may be due to deletion of one copy of GATA4 gene and mutation in the other allele, also we suggest that PINX1 gene may be a sharing gene for anonychia. Combined karyotype, FISH, array CGH, sequencing analysis, and in silico analysis are crucial in genotype-phenotype correlation.

  • Open Access

    Effect of Combined Cognitive and Motor Intervention on Muscles Strength, Balance and Daily Activities among Elderly at Risk for Falls

    by Amal H. Mohamed, Fayza M. Mohammed, Amira A. El-Houfey, Soher Ahmed Awad, Aml S. Abdelbaky

    Background: One in three seniors falls at least once a year, making falls a serious public health concern. Increased mortality, injuries, loss of independence, and unfavorable psychosocial effects are all linked to falls. Aim of the study: To evaluate the effect of combined cognitive and motor interventions on muscle strength, balance, and daily activities among elderly people at risk for falls. Subjects and method: Design: A quasi-experimental study (study/control) was used in the current study. Setting: the study conducted at six geriatric homes at Minia governorate. Subject: total coverage of the elderly at selected places was comprised in the study. Tools of data collection: Four tools were used to gather data for this study: Structured interviewing sheet; Medical Research Council Scale for Muscle Strength and Berg Balance Scale and The Katz Activities of Daily Living. Results: It was found that, combined cognitive & motor exercises group had the highest scores for muscle strength, maintain balance, and becoming independently in performing activity of daily living (ADLs) post 24-week of exercises, compared with the control group. Conclusion: Combined cognitive and motor exercise interventions had an adequate influence on the improvement of balance, gait, activity of daily living, and muscle strength in the upper and lower limbs and decreased the risk of falling compared to motor intervention alone. Recommendation: Health education among elderly about the effects of combined and cognitive training exercises on balance, muscle strength, and activities of daily living through effective teaching media such as videos, role play, and demonstration.


  • Open Access

    Genetics of Retinoblastoma

    by Amal Mohamed, Ola M Eid, Alaa K Kamel, Hanan H. Afifi

    Background: Retinoblastoma (Rb) is the most common primary intraocular tumor in childhood. This review covers the causes, modes of inheritance, genetic testing, and recurrence risk of retinoblastoma, as well as disease management and the experience of the Centre of Excellence for Human Genetics at the National Research Centre in dealing with Rb. The incidence of Rb is approximately one in every 16,000-18,000 live births, affecting around 8,000 children worldwide each year. More than 80% of these cases are from low- and middle-income countries, with 50% of patients in Asia and 25% in Africa. The survival rate exceeds 95% in high-income countries, while the mortality rate can reach up to 70% in low-income countries. Rb can affect one or both eyes. In hereditary cases, there is a 50% chance of transmitting the affected allele to the next generation. The primary gene responsible for Rb is the retinoblastoma gene (RB1), located on chromosome 13q14. Most mutations causing Rb are within the RB1 gene, a tumor suppressor gene. Retinoblastoma requires mutations in both alleles (biallelic mutation) to develop into cancer. The RB1 gene product, retinoblastoma protein, plays several roles in retina development, cell division checkpoints, DNA replication, and apoptosis. In some cases, other genes such as MYCN and BCOR, as well as epigenetic factors, may contribute to Rb. Early diagnosis and appropriate treatment significantly improve survival rates. Recent advancements in molecular diagnosis have greatly impacted Rb management. This review aims to raise awareness about the disease, emphasizing the importance of early diagnosis and management to provide affected children and their families with better outcomes and the possibility of a complete cure.


  • Open Access

    Chromosome 9p terminal deletion in nine Egyptian patients and narrowing of the critical region for trigonocephaly

    by Amal M. Mohamed, Alaa K. Kamel, Maha M. Eid, Ola M. Eid, Mona Mekkawy, Shymaa H. Hussein, Maha S. Zaki, Samira Esmail, Hanan H. Afifi, Ghada Y. El‐Kamah, et al.

    Background: This study aimed to delineate the clinical phenotype of patients with 9p deletions, pinpoint the chromosomal breakpoints, and identify the critical region for trigonocephaly, which is a frequent finding in 9p terminal deletion.Methods: We investigated a cohort of nine patients with chromosome 9p terminal deletions who all displayed developmental delay, intellectual disability, hypotonia, and dysmorphic features. Of them, eight had trigonocephaly, seven had brain anomalies, seven had autistic manifestations, seven had fair hair, and six had a congenital heart defect (CHD).Results: Karyotyping revealed 9p terminal deletion in all patients, and patients 8 and 9 had additional duplication of other chromosomal segments. We used six bacterial artificial chromosome (BAC) clones that could identify the breakpoints at 17–20 Mb from the 9p terminus. Array CGH identified the precise extent of the deletion in six patients; the deleted regions ranged from 16 to 18.8 Mb in four patients, patient 8 had an 11.58 Mb deletion and patient 9 had a 2.3 Mb deletion.Conclusion: The gene deletion in the 9p24 region was insufficient to cause ambiguous genitalia because six of the nine patients had normal genitalia. We suggest that the critical region for trigonocephaly lies between 11,575 and 11,587 Mb from the chromosome 9p terminus. To the best of our knowledge, this is the minimal critical region reported for trigonocephaly in 9p deletion syndrome, and it warrants further delineation.


  • Role of MicroRNAs (224 and 96) as Novel Biomarkers for Hepatocellular Carcinoma

    by Amal A. Mohamed, Mokhtar M. El-Zawahry, Omnia I. Tantawi, Amyan Aalkhalegy, Lamiaa Abdelfattah Fathalla, Yousry Esam-Eldin Abo-Amer, Mostafa Bedair Elmaghraby, Mohamed Mahmoud Elhoseeny, Mohamed El-Abgeegy, Sahar Mohamed Mostafa, et al.

    Background:: In the early stages of HCC, it is unsatisfactory to depend on alpha-fetoprotein for diagnosis. Objective:: The current study evaluated the possibility of the two miRNAs which are miRNA-96 and miRNA-224 to act as biomarkers for HCC diagnosis. Methods:: This study included 50 patients with HCV-induced HCC and 50 patients with HCV-induced liver cirrhosis for comparison as well as 67 healthy volunteers as controls. All participants were subjected to history taking, clinical examination, and laboratory investigations as well as quantification of serum miRNA-96 and miRNA-224 by real-time quantitative PCR. Results:: MicroRNA 224 level was significantly higher in HCC than the other two groups and was significantly higher in liver cirrhosis than the control group. MicroRNA 96 level was higher in HCC than the control group and was higher in cirrhotic group than both HCC and control groups. However, it doesn’t reach the statistical significance level. The best cut-off value of microRNA 96 for detecting HCC was 3.414 with a sensitivity of 67% and a specificity of 67%, (p-value Conclusion:: miRNA-224 could serve as a biomarker for the HCC diagnosis.

  • Open Access

    Developing a Road Map to Spread Genomic Knowledge in Africa: 10th Conference of the African Society of Human Genetics, Cairo, Egypt

    by Ghada Y. El-Kamah, Amal M. Mohamed, Yehia Z. Gad, Sonia Abdelhak, Branwen J. Hennig, Raj S. Ramesar, Guida Landouré, Amadou Gaye, Melanie J. Newport, Scott M. Williams, et al.

    The tenth conference of the African Society of Human Genetics was held in Egypt with the theme “Human Genetics and Genomics in Africa: Challenges for Both Rare and Common Genetic Disorders.” Current research was presented, and we discussed visions for the future of genomic research on the African continent. In this report, we summarize the presented scientific research within and relevant to Africa as presented by both African and non-African scientists. We also discuss the current situation concerning genomic medicine and genomic research within the continent, difficulties in implementing genetic services and genomic medicine in Africa, and a road map to overcome those difficulties and meet the needs of the African researchers and patients.